Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Artificial Intelligence Comes to the Life Sciences

Posted on September 18th, 2017 by in Pharma R&D

Advances in neural network technology are making it possible to ‘teach’ machines more rapidly—and this machine learning can have big implications for the healthcare and life sciences industry. Continue reading “Artificial Intelligence Comes to the Life Sciences” »

The Eternal Triangle of Quality, Speed, and Cost

Posted on August 7th, 2017 by in Pharma R&D

triangle-869123_640
A designer colleague once described to me the key issue involved in many of their creative design projects. It is finding the best balance between quality, speed, and cost. From a buyer perspective, we desire high quality, rapid delivery, and low cost. Continue reading “The Eternal Triangle of Quality, Speed, and Cost” »

Assessing the State of the Genomic Revolution

Posted on May 29th, 2017 by in Pharma R&D

A few weeks ago, a number of experts in the field of genomics gathered in downtown Manhattan for Sequencing the Genome: Examining Modern Medicine, an event hosted by The Atlantic magazine. Continue reading “Assessing the State of the Genomic Revolution” »

Personalized vs. Precision Medicine

Posted on February 3rd, 2017 by in Pharma R&D

Last year was a year of impetus for precision medicine. Former President Obama’s budget for the 2016 fiscal year included $215 million for the National Institutes of Health (NIH), Continue reading “Personalized vs. Precision Medicine” »

  1. 1
  2. 2